| Navigation |
SuperNutrient Links:
|
|
| Flu |
The Best Defense | THE DMPS ADVOCATES | Glutathione helps Immune system | Thimerosal and Formaldehyde | Flu Vaccine Not Working | Flu Shots | The Truth Behind the Vaccine Coverup
The Truth Behind the Vaccine Coverup 9/22/04. This information is provided by
Mercola.com, the world's most visited and trusted natural health website. You
can keep current on all the exciting new natural health news by subscribing to
the free weekly health newsletter at Mercola.com.
The Truth Behind the Vaccine Coverup
Dr. Mercola's Comment:
I find it almost incomprehensible that thimerosal, the well-documented, toxic
mercury-containing preservative, is still in many vaccines, years after federal
agencies have mandated that it be removed from vaccines. Most people, physicians
included, don't understand that thimerosal is still used in most vaccines and is
likely one of the major contributing factors to vaccine toxicity.
Mercury is a potent neurotoxin. Injecting it into a child, whose nervous system
is rapidly developing, could have terrible consequences. So, before you decide
to vaccinate your children, do them a favor and look into the many risks and
side effects associated with common childhood vaccines. Doing so could mean the
difference between life and death.
When my colleague and regular columnist, Dr. Russell Blaylock, forwarded me his
latest manuscript, I was shocked and dismayed to read his review of a secret
2000 meeting between CDC officials and scientists about the use of thimerosal. I
believe you will be too which is why I posted his entire manuscript and it will
be posted over the upcoming issues. So please be sure and read the entire
fascinating story.
By Russell L. Blaylock, M.D.
I was asked to write a paper on some of the newer mechanisms of vaccine damage
to the nervous system, but, in the interim, I came across an incredible document
that should blow the lid off the coverup being engineered by the pharmaceutical
companies in conjunction with powerful governmental agencies.
It all started when a friend of mine sent me a copy of a letter from Congressman
David Weldon (R-Fla.), M.D. to the director of the CDC, Dr Julie L. Gerberding,
in which he alludes to a study by a Dr. Thomas Verstraeten, then representing
the CDC, on the connection between infant exposure to thimerosal-containing
vaccines and neurodevelopmental injury.
In this shocking letter, Weldon refers to Dr. Verstraeten's study which looked
at the data from the Vaccine Safety Datalink and found a significant correlation
between thimerosal exposure via vaccines and several neurodevelopmental
disorders including tics, speech and language delays and possibly to ADD.
Weldon questioned the CDC director as to why, following this meeting, Dr.
Verstraeten published his results, almost four years later, in the journal
Pediatrics to show just the opposite. That is, there was no correlation to any
neurodevelopmental problems related to thimerosal exposure in infants. In his
letter, Weldon refers to a report of the minutes of this meeting held in
Georgia, which exposes some incredible statements by the "experts" making up
this study group.
The group's purpose was to evaluate and discuss Dr. Verstraeten's results and
data and make recommendation that would eventually lead to possible alterations
in the existing vaccine policy.
Pulling Teeth
I contacted Weldon's legislative assistant and he kindly sent me a complete copy
of this report. Now, as usual in these cases, the government did not give up
this report willingly. It required a Freedom of Information Act lawsuit to pry
it loose. Having read the report twice and carefully analyzing it, I can see why
they did not want any outsiders to look at it. It is a bombshell, as you shall
see.
In this analysis, I will not only describe and discuss this report, but also
will frequently quote their words directly and supply the exact page number so
others can see for themselves.
The official title of the meeting was the "Scientific Review of Vaccine Safety
Datalink Information." This conference, held on June 7-8, 2000 at the
Simpsonwood Retreat Center, Norcross, Ga., assembled 51 scientists and
physicians of which five represented vaccine manufacturers (Smith Kline Beecham,
Merck, Wyeth, North American Vaccine and Aventis Pasteur).
During this conference, these scientists focused on the study of the Datalink
material, whose main author was Dr. Thomas Verstraesten who identified himself
as working at the National Immunization Program of the CDC.
(It was discovered by Congressman Weldon that Dr. Verstraeten left the CDC
shortly after this conference to work for GlaxoSmithKline in Belgium which
manufacturers vaccines, a recurring pattern that has been given the name a
"revolving door." It is also interesting to note that GlaxoSmithKline was
involved in several lawsuits over complications secondary to their vaccines.)
To start off the meeting Dr. Roger Bernier, Associate Director for Science in
the National Immunization Program (CDC), related some pertinent history. He
stated that congressional action in 1977 required that the FDA review mercury
being used in drugs and biologics (vaccines). In meeting this order, the FDA
called for information from the manufacturers of vaccines and drugs. He notes
that a group of European regulators and manufacturers met on April 1999 and
noted the situation but made no recommendations of changes.
In other words, it was all for show.
The Lid Blown Off
At this point, Dr. Bernier made an incredible statement (page 12). He said, "In
the United States, there was a growing recognition that cumulative exposure may
exceed some of the guidelines." By guidelines, he is referring to those for
mercury exposure safety levels set by several regulatory agencies. The three
guidelines were set by the Agency for Toxic Substances and Disease Registry
(ATSDR), FDA and EPA. The most consistently violated safety guideline was that
set by EPA. He further explains that he is referring to children being exposed
to thimerosal in vaccines.
Based on this realization that they were violating safety guidelines he says,
this then "resulted in a joint statement of the Public Health Service (PHS) and
the American Academy of Pediatrics (AAP) in July of last year (1999), which
stated that as a long term goal, it was desirable to remove mercury from
vaccines because it was a potentially preventable source of exposure." (Page 12)
As an aside, one has to wonder, where was the Public Health Service and American
Academy of Pediatrics during all the years of mercury use in vaccines and why
didn't they know that:
They were exceeding regulatory safety levels.
Why weren't they aware of the extensive literature showing deleterious effects
on the developing nervous system of babies?
As we shall see even these "experts" seem to be cloudy on the mercury
literature.
An Earlier Meeting
Dr. Bernier notes that in August 1999, a public workshop was held in Bethesda,
Md., at the Lister Auditorium by the National Vaccine Advisory Group and the
Interagency Working Group on Vaccines to consider thimerosal risk in vaccine
use. And based on what was discussed in that conference, thimerosal was removed
from the hepatitis B vaccine (HepB).
It is interesting to note that the media took very little interest in what was
learned at that meeting and it may have been a secret meeting as well. As we
shall see, there is a reason why they struggle to keep the contents of all these
meetings secret from the public.
Bernier then notes, on page 13, that in October 1999, the Advisory Committee on
Immunization Practices (ACIP) "looked this situation over again and did not
express a preference for any of the vaccines that were thimerosal free." In this
discussion, he further notes the ACIP concluded that the thimerosal-containing
vaccines could be used but the "long-term goal is to try to remove thimerosal as
soon as possible."
Now, we need to stop and think about what has transpired here. We have an
important group here -- the ACIP -- that essentially plays a role in vaccine
policy that affects tens of millions of children every year. And, we have
evidence from the thimerosal meeting in 1999 that the potential for serious
injury to the infant's brain is so serious that a recommendation for removal
becomes policy.
In addition, they are all fully aware that tiny babies are receiving mercury
doses that exceed even EPA safety limits, yet all they can say is that we must
"try to remove thimerosal as soon as possible?" Do they not worry about the tens
of millions of babies that will continue receiving thimerosal-containing
vaccines until they can get around to stopping the use of thimerosal?
The Obvious Solution
It should also be noted that it is a misnomer to say "removal of thimerosal"
since they are not removing anything. They just plan to stop adding it to future
vaccines once they use up existing stocks, which entails millions of doses. And,
incredibly, the government allows them to do it.
Even more incredibly, the American Academy of Pediatrics and the American
Academy of Family Practice similarly endorse this insane policy. In fact, they
specifically state that children should continue to receive the
thimerosal-containing vaccines until new thimerosal-free vaccines can be
manufactured at the will of the manufacturers. Are they afraid that there will
be a sudden diphtheria epidemic in America or tetanus epidemic?
The most obvious solution was to use only single-dose vials, which requires no
preservative. So why don't they use them?
Oh, they exclaim, it would add to the cost of the vaccine. Of course, we are
only talking about a few dollars per vaccine at most, certainly worth the health
of your child's brain and future. They could use some of the hundreds of
millions of dollars they waste on vaccine promotion every year to cover these
costs for the poor. Then, that would cut into some "fat cat's" budget and we
can't have that.
It was disclosed that thimerosal was in all influenza vaccines, DPT (and most
DtaP) vaccines and all HepB vaccines.
As they begin to concentrate on the problem at hand we first begin to learn that
the greatest problem with the meeting is that, they know virtually nothing about
what they are doing. On page 15, for example, they admit that there is very
little pharmacokinetic data on ethylmercury, the form of mercury in thimerosal.
In fact, they say there is no data on excretion and the data on toxicity is
sparse. Yet it is recognized to cause hypersensitivity, neurological problems
and even death, and it is known to easily pass the blood-brain and placental
barriers.
No Research?
Therefore, what they are admitting is that we have a form of mercury
that has been used in vaccines since the 1930s and no one has
bothered to study its effects on biological systems, especially the
brain of infants. Their defense throughout this conference is "We
just don't know the effects of ethylmercury." As a solution, they
resort to studies on methylmercury, because there are thousands of
studies on this form of mercury. The major source of this form is
seafood consumption.
It takes them a while to get the two forms of mercury straight,
since for several pages of the report they say methylmercury is in
thimerosal rather than ethylmercury. They can be forgiven for this.
On page 16, Dr. Johnson, an immunologist and pediatrician at the
University of Colorado School of Medicine and the National Jewish
Center for Immunology and Respiratory Medicine, notes that he would
like to see the incorporation of wide margins of safety, that is 3
to 10-fold margins of safety to "account for data uncertainties."
What he means: There are so many things we do not know about this
toxin that we had better use very wide margins of safety. For most
substances, the FDA uses a 100-fold margin of safety.
The reason for this, which they do not mention, is that in a society
of hundreds of millions of people, there are groups of people who
are much more sensitive to the toxin than others. For instance:
The elderly
Chronically ill
Nutritionally deficient
Small babies
Premature babies
People on certain medications
Inborn defects in detoxification
In fact, in this study they excluded premature babies and low birth
weight babies from the main study, some of which had the highest
mercury levels, because they would be hard to study and because they
had the most developmental problems related to the mercury.
Who Are You?
On page 16, Dr. Johnson makes an incredible statement, one that
defines the problem we have in this country with the promoters of
these vaccines. "As an aside, we found a cultural difference between
vaccinologist and environmental health people in that many of us in
the vaccine arena have never thought about uncertainty factors
before. We tend to be relatively concrete in our thinking."
Then he says, "One of the big cultural events in that meeting -- was
when Dr. Clarkson repetitively pointed out to us that we just didn't
get it about uncertainty, and he was actually quite right."
This is an incredible admission. First, what is a vaccinologist? Do
you go to school to learn to be one? How many years of residency
training are required to be a vaccinologist? Are there board exams?
It's a stupid term used to describe people who are obsessed with
vaccines, not that they actually study the effects of the vaccines,
as we shall see throughout this meeting.
Most important is the admission by Dr. Johnson that he and his
fellow "vaccinologists" are so blinded by their obsession with
forcing vaccines on society that they never even considered that
there might be factors involved that could greatly affect human
health, the so-called "uncertainties."
Further, he and his fellow "vaccinologists" like to think in
concrete terms. That is, they are very narrow in their thinking and
wear blinders that prevent them from seeing the numerous problems
occurring with large numbers of vaccination in infants and children.
Their goal in life is to vaccinate as many people as possible with
an ever-growing number of vaccines.
On page 17, his "concrete thinking" once again takes over. He refers
to the Bethesda meeting on thimerosal safety issues and says, "There
was no evidence of a problem, only a theoretical concern that young
infants' developing brains were being exposed to an
organomercurial." Of course, as I shall point out later, it is a lot
more than a "theoretical concern."
He then continues by saying, "We agree that while there was no
evidence of a problem the increasing number of vaccine injections
given to infants was increasing the theoretical mercury exposure
risk."
The Ultimate Irony
It's hard to conceive of a true scientist not seeing the incredible
irony of these statements.
Medical literature is abound with studies on the deleterious effects
of mercury on numerous enzymes, mitochondrial energy production,
synaptic function, dendritic retraction, neurotubule dissolution and
excitotoxicity. Yet, he sees only a "theoretical risk" associated
with an ever increasing addition of thimerosal-containing vaccines.
It is also important to note that these geniuses never even saw a
problem in the first place. It was pressure from outside scientists,
parents of affected children and groups representing them that
pointed out the problem. They were, in essence, reacting to pressure
from outside the "vaccinologist club" and not discovering internally
that a problem "might" exist.
In fact, if these outside groups had not become involved, these
"vaccinologists" would have continued to add more and more
mercury-containing vaccines to the list of required vaccines. Only
when the problem became so obvious -- that is of epidemic proportion
(close to that now) and the legal profession became involved --
would they have even noticed there was a problem. This is a
recurring theme in the government's regulatory agencies, as
witnessed with fluoride, aspartame, MSG, dioxin and pesticides
issues.
It is also interesting that Dr. Johnson did admit that the greatest
risk was among low birth weight infants and premature infants. Now
why would that be if there existed such a large margin of safety
with mercury used in vaccines? Could just a few pounds of body
weight make such a dramatic difference?
In fact, it does but it also means that normal birth weight
children, especially those near the low range of normal birth
weight, are also in greater danger. It also would mean that children
receiving doses of mercury higher than the 72 ug in this study would
be at high risk as well because their dose, based on body weight,
would be comparable to that of the low birth weight child receiving
the lower dose.
This was never even considered by these "vaccinologist experts" who
decide policy for your children.
References for "The Truth Behind the Vaccine Coverup"
Lorscheider,FL; Vimy,MJ; Pendergrass,JC; Haley,BE. Mercury vapor
exposure inhibits tubulin binding to GTP in rat brain: A molecular
lesion also present in human Alzheimer brain From: FASEB J. 9(4):
A-3845. FASEB Annual Meeting, Atlanta, Georgia, 10 March 1995.
Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P,
Debes F, Keiding N Methylmercury exposure biomarkers as indicators
of neurotoxicity in children aged 7 years. From: Am J Epidemiol
1999 Aug 1;150(3):301-5
Albers JW, Kallenbach LR, Fine LJ, Langolf GD, Wolfe RA, Donofrio
PD, Alessi AG, Stolp-Smith KA, Bromberg MB Neurological
abnormalities associated with remote occupational elemental
mercury exposure. Ann Neurol 1988 Nov;24(5):651-9
Aschner M, Lorscheider FL, Cowan KS, Conklin DR, Vimy MJ, Lash LH
Metallothionein induction in fetal rat brain and neonatal primary
astrocyte cultures by in utero exposure to elemental mercury vapor
(Hg0). From: Brain Res 1997 Dec 5;778(1):222-32
Soederstroem S, Fredriksson A, Dencker L & Ebendal T The effect of
mercury vapour on cholinergic neurons in the fetal brain: studies
on the expression of nerve growth factor and its low- and
high-affinity receptors. Developmental Brain Research 85(1):96-108
(1995)
Drasch G, Schupp I, Hofl H, Reinke R & Roider G. Mercury burden of
human fetal and infant tissues. Eur J Pediatr 153:607-610 (1994)
Szucs A, Angiello C, Salanki J, Carpenter DO Effects of inorganic
mercury and methylmercury on the ionic currents of cultured rat
hippocampal neurons. Cell Mol Neurobiol 1997 Jun;17(3):273-88
Low-Level Exposure to Methylmercury Modifies Muscarinic
Cholinergic Receptor Binding Characteristics in Rat Brain and
Lymphocytes: Physiologic Implications and New Opportunities in
Biologic Monitoring Teresa Coccini,1 Giovanna Randine,2 Stefano M.
Candura,1,3 Rossella E. Nappi,2,3 Leon D. Prockop,4 and Luigi
Manzo
Sorg O, Schilter B, Honegger P, Monnet-Tschudi F Increased
vulnerability of neurones and glial cells to low concentrations of
methylmercury in a prooxidant situation. Acta Neuropathol (Berl)
1998 Dec;96(6):621-7
Liang YX, Sun RK, Sun Y, Chen ZQ, Li LH Psychological effects of
low exposure to mercury vapor: application of a
computer-administered neurobehavioral evaluation system. Environ
Res 1993 Feb;60(2):320-7 Sundberg J, Jonsson S, Karlsson MO,
Oskarsson A Lactational exposure and neonatal kinetics of
methylmercury and inorganic mercury in mice. Toxicol Appl
Pharmacol 1999 Jan 15;154(2):160-9
Inouye M., Murao K., Kajiwara Y., Behavorial and neuropathological
effects of prenatal methyl Mercury exposure in mice..
Neurobehav.Toxicol Teratol. ,1985:7;227-232
Koos et al., Mercury toxicity in pregnant women, fetus and newborn
infant. Am J Obstet And Gynecol., 1976:126;390-409
Khera et al., Teratogenic and genetic effects of Mercury toxicity.
The biochemistry of Mercury in the environment. Nriagu, J.O.Ed
Amsterdam Elsevier, 503-18,1979
Drasch G, Schupp I, Hofl H, Reinke R, Roider G Mercury burden of
human fetal and infant tissues. Eur J Pediatr 1994
Aug;153(8):607-10
Yoshida M, Yamamura Y, Satoh H Distribution of mercury in guinea
pig offspring after in utero exposure to mercury vapor during late
gestation Arch Toxicol 1986 Apr;58(4):225-8 .
Yuan,Y; Atchison,WD. Comparative effects of inorganic divalent
mercury, methylmercury and phenylmercury on membrance excitability
and synaptic transmission of CA1 neurons in hippocampal slices of
the rat Neurotoxicology. 14(2):403-411, 1994.
Desi I, Nagymajtenyi L, Schulz H Effect of subchronic mercury
exposure on electrocorticogram of rats. Neurotoxicology 1996
Fall-Winter;17(3-4):719-23
Bucio L, Garcia C, Souza V, Hernandez E, Gonzalez C, Betancourt M,
Gutierrez-Ruiz MC Uptake, cellular distribution and DNA damage
produced by mercuric chloride. Mutat Res 1999 Jan
25;423(1-2):65-72
Hua MS, Huang CC, Yang YJ Chronic elemental mercury intoxication:
neuropsychological follow-up case study. Brain Inj 1996
May;10(5):377-84
Grandjean P, Weihe P, White RF, Debes F Cognitive performance of
children prenatally exposed to "safe" levels of methylmercury.
Environ Res 1998 May;77(2):165-72
Hock C, Drasch G, Golombowski S, Muller-Spahn F,
Willershausen-Zonnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM
Increased blood mercury levels in patients with Alzheimer's
disease. J Neural Transm 1998;105(1):59-68
Oskarsson A, Palminger Hallen I & Sundberg J. Exposure to toxic
elements via breast milk. Analyst 120(3):765-770 (1995)
Hock C, Drasch G, Golombowski S, Muller-Spahn F,
Willershausen-Zonnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM
Increased blood mercury levels in patients with Alzheimer's
disease. J Neural Transm 1998;105(1):59-68
Wenstrup D, Ehmann WD, Markesbery WR Trace element imbalances in
isolated subcellular fractions of Alzheimer's disease brains.
Brain Res 1990 Nov 12;533(1):125-31
Basun H, Forssell LG, Wetterberg L, Winblad B Metals and trace
elements in plasma and cerebrospinal fluid in normal aging and
Alzheimer's disease. J Neural Transm Park Dis Dement Sect
1991;3(4):231-58
Hock C, Drasch G, Golombowski S, Muller-Spahn F,
Willershausen-Zonnchen B, Schwarz P, Hock U, Growdon JH, Nitsch RM
Increased blood mercury levels in patients with Alzheimer's
disease. J Neural Transm 1998;105(1):59-68
Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL
Mercury vapor inhalation inhibits binding of GTP to tubulin in rat
brain: similarity to a molecular lesion in Alzheimer diseased
brain. Neurotoxicology 1997;18(2):315-24
Opitz H, Schweinsberg F, Grossmann T, Wendt-Gallitelli MF,
Meyermann R Demonstration of mercury in the human brain and other
organs 17 years after metallic mercury exposure. Clin Neuropathol
1996 May-Jun;15(3):139-44
Sanfeliu C, Sebastia J, Cristofol R, Rodriguez-Farre E.
Neurotoxicity of organomercurial compounds. Neurotox Res.
2003;5(4):283-305.
el-Fawal HA, Gong Z, Little AR, Evans HL Exposure to methylmercury
results in serum autoantibodies to neurotypic and gliotypic
proteins.Neurotoxicology 1996 Summer;17(2):531-9
Faustman EM, Ponce RA, Ou YC, Mendoza MA, Lewandowski T, Kavanagh
T. Investigations of methylmercury-induced alterations in
neurogenesis. Environ Health Perspect. 2002 Oct;110 Suppl
5:859-64.
Reading R. Thimerosal and the occurrence of autism: negative
ecological evidence from Danish population-based data. Child Care
Health Dev. 2004 Jan;30(1):90-1.
Qvarnstrom J, Lambertsson L, Havarinasab S, Hultman P, Frech W.
Determination of methylmercury, ethylmercury, and inorganic
mercury in mouse tissues, following administration of thimerosal,
by species-specific isotope dilution GC-inductively coupled
plasma-MS. Anal Chem. 2003 Aug 15;75(16):4120-4.
Shanker G, Syversen T, Aschner M. Astrocyte-mediated methylmercury
neurotoxicity. Biol Trace Elem Res. 2003 Oct;95(1):1-10.
Zheng W, Aschner M, Ghersi-Egea JF. Brain barrier systems: a new
frontier in metal neurotoxicological research. Toxicol Appl
Pharmacol. 2003 Oct 1;192(1):1-11.
Kawase T, Ishikawa I, Orikasa M, Suzuki A. An assessment of the
impact of thimerosal on childhood neurodevelopmental disorders.
Geier DA, Geier MR. J Biochem (Tokyo). 1989 Jul; 106(1): 8-10.
Aluminum enhances the stimulatory effect of NaF on prostaglandin
E2 synthesis in a clonal osteoblast-like cell line, MOB 3-4, in
vitro. Pediatr Rehabil. 2003 Apr-Jun;6(2):97-102.
Geier MR, Geier DA. Thimerosal in childhood vaccines,
neurodevelopmental disorders, and heart disease in the United
States. J Amer Physc Surg 8: 6-11, 2003.
Allen JW, Shanker G, Tan KH, Aschner M. The consequences of
methylmercury exposure on interactive functions between astrocytes
and neurons. Neurotoxicology 23: 755-759, 2002.
Hansen JC, Reske-Nielsen E, et al. Distribution of dietary mercury
in a dog. Quantitation and localization of total mercury in organs
and central nervous system. Sci Total Environ 78: 23-43, 1989.
Zanoli P, Cannazza G, Baraldi M. Prenatal exposure to methyl
mercury in rats: focus on changes in kyrenine pathway. Brain Res
Bull 55: 235-238, 2001.
Olivieri G, Brack C, et al. Mercury induces cell cytotoxicity and
oxidative stress and increases beta-amyloid secretion and tau
phosphorylation in SHY5Y neuroblastoma cells. J Neurochem 74:
231-236, 2000.
Juarez BI, Mattinez M, et al. Methylmercury increases glutamate
extracellular levels in frontal cortex of awake rats.
Neurotoxicology and Teratology 24: 767-771, 2002.
Geier DA, Geier MR. An assessment of the impact of thimerosal on
childhood neurodevelopmental disorders. Pediatric Rehabil 6:
97-102, 2003.
Geier DA, Geier MR. A comparative evaluation of the effects of MMR
immunization and mercury doses from thimerosal-containing
childhood vaccines on the population prevalence of autism. Med Sci
Monit 10: P133-139, 2004. Baskin DS, Ngo H, Didenko VV. Thimerosal
indices DNA breaks, caspase-3 activation, membrane damage, and
cell death in cultured human neurons and fibroblast. Toxicol Sci
74: 361-368, 2003.
Pichichero ME, et al. Mercury concentrations and metabolism in
infants receiving vaccines containing thimerosal: a descriptive
study. Lancet 360: 1737-1741, 2002.
Murata K, Dakeishi M. Impact of prenatal methylmercury exposure on
child neurodevelopment in the Faroe Islands. Nippon Eiseigaku
Zasshi 57: 564-570, 2002.
Davidson PW, Myers GJ, et al (Clarkson TW-member of panel) Effects
of prenatal and postnatal exposure from fish consumption on
neurodevelopment: outcomes at 66 months of age in the Seychelles
Child Development Study. JAMA 280: 701-707, 1998.
Palumbo DR, Cox C, et al. (ClarksonTW) Association between
prenatal exposure to methylmercury and cognitive functioning in
Seychellois children: a reanalysis of the McCarthy Scales of
Children's Ability from the main cohort study. Environ Res 84:
81-88, 2000.
Hornig M, Chian D, Lipkin WI. Neurotoxic effects of postnatal
thimerosal are mouse strain dependent. Mol Psychiatry (In press)
Ueha-Ishibashi T, et al. Property of thimerosal-induced decrease
in cellular content of gluatathione in rat thymocytes: a flow
cytometric study with 5-chloromethylfluorescein. Toxicol in Vitro
18: 563-569, 2004.
Ueha-Ishibaschi T, et al. Effect of thimerosal, a preservative in
vaccines, on intracellular Ca+2 concentration of ra cerebellar
neurons. Toxicology 195: 77-84, 2004.
Havarinasab S, Lambertsson L, et al. Dose-response study of
thimerosal-induced murine systemic autoimmunity. Toxicol Appl
Pharmacol 194: 169-179, 2004.
Verstraeten T, Davis RL, DeStefano F, et al. Safety of
thimerosal-containing vaccines: a two-phase study of computerized
health maintenance organization databases. Pediatrics 112:
1039-1048, 2003. (This is the published study that was discussed
in the conference. Here the damaging data is erased and the public
is told the thimerosal-containing vaccines are perfectly safe. In
this paper Dr. Verstraeten identified himself as working for the
CDC, but in fact he is working for GlaxoSmithKline. The editors of
the journal Pediatrics should have been willing to disclose this
information once it was brought to their attention but they would
not.)
Aluminum References
Murayama H, Shin RW, Higuchi J, Shibuya S, Muramoto T, Kitamoto T.
Interactionof aluminum with PHFtau in Alzheimer's disease
neurofibrillary degeneration evidenced by desferrioxamine-assisted
chelating autoclave method.Am J Pathol. 1999 Sep;155(3):877-85.
Shin RW, Kruck TP, Murayama H, Kitamoto T. A novel trivalent
cation chelator Feralex dissociates binding of aluminum and iron
associated with hyperphosphorylated tau of Alzheimer's disease.
Brain Res. 2003 Jan 24;961(1):139-46
Li W, Ma KK, Sun W, Paudel HK. Phosphorylation sensitizes
microtubule-associated protein tau to Al(3+)-induced aggregation.
Neurochem Res. 1998 Dec;23(12):1467-76.
Singer SM, Chambers CB, Newfry GA, Norlund MA, Muma NA. Tau in
aluminum-induced neurofibrillary tangles. Neurotoxicology.
1997;18(1):63-76.
Toda S, Yase Y. Effect of aluminum on iron-induced lipid
peroxidation and protein oxidative modification of mouse brain
homogenate. Biol Trace Elem Res. 1998 Feb;61(2):207-17.
Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In
situ oxidative catalysis by neurofibrillary tangles and senile
plaques in Alzheimer's disease: a central role for bound
transition metals. J Neurochem. 2000 Jan;74(1):270-9.
Xie CX, Yokel RA. Aluminum facilitation of iron-mediated lipid
peroxidation is dependent on substrate, pH and aluminum and iron
concentrations. Arch Biochem Biophys. 1996 Mar 15;327(2):222-6.
Kawase T, Ishikawa I, Orikasa M, Suzuki A. Aluminum enhances the
stimulatory effect of NaF on prostaglandin E2 synthesis in a
clonal osteoblast-like cell line, MOB 3-4, in vitro. J Biochem
(Tokyo). 1989 Jul; 106(1): 8-10.
Jope RS. Modulation of phosphoinositide hydrolysis by NaF and
aluminum in rat cortical slices. J Neurochem. 1988 Dec; 51(6):
1731-6.
Blair HC, Finch JL, Avioli R, Crouch EC, Slatopolsky E, Teitelbaum
SL. Micromolar aluminum levels reduce 3H-thymidine incorporation
by cell line UMR 106-01. Kidney Int. 1989 May; 35(5): 1119-25.
Shainkin-Kestenbaum R, Adler AJ, Berlyne GM, Caruso C. Effect of
aluminium on superoxide dismutase. Clin Sci (Lond). 1989 Nov;
77(5): 463-6.
Kawase T, Orikasa M, Suzuki A. Aluminofluoride- and epidermal
growth factor-stimulated DNA synthesis in MOB 3-4-F2 cells.
Pharmacol Toxicol. 1991 Nov; 69(5): 330-7.
Gomes MG, Moreira CA, Mill JG, Massaroni L, Oliveira EM, Stefanon
I, Vassallo DV. Effects of aluminum on the mechanical and
electrical activity of the Langendorff-perfused rat heart. Braz J
Med Biol Res. 1994 Jan; 27(1): 95-100.
Jope RS. Modulation of phosphoinositide hydrolysis by NaF and
aluminum in rat cortical slices. J Neurochem. 1988 Dec; 51(6):
1731-6.
Husaini Y, Rai LC, Mallick N. Impact of aluminium, fluoride and
fluoroaluminate complex on ATPase activity of Nostoc linckia and
Chlorella vulgaris. Biometals. 1996 Jul; 9(3): 277-83.
Blair HC, Finch JL, Avioli R, Crouch EC, Slatopolsky E, Teitelbaum
SL. Micromolar aluminum levels reduce 3H-thymidine incorporation
by cell line UMR 106-01. Kidney Int. 1989 May; 35(5): 1119-25.
Lai JC, Lim L, Davison AN. Effects of Cd2+, Mn2+, and Al3+ on rat
brain synaptosomal uptake of noradrenaline and serotonin. J Inorg
Biochem. 1982 Nov; 17(3): 215-25.
Shainkin-Kestenbaum R, Adler AJ, Berlyne GM, Caruso C. Effect of
aluminium on superoxide dismutase. Clin Sci (Lond). 1989 Nov;
77(5): 463-6.
Department of Health and Human Services National Vaccine Program
Office Presents: Workshop on Aluminum in Vaccines. Caribe Hilton
International Hotel, San Juan, Puerto Rico: Jointly sponsored by:
task Force for Child Survival and Development. May 12, 200.
Varner JA, Jenson KF, Harvath W, Isaacson RL. Chronic
administration of aliminum-fluoride or sodium-fluoride to rats in
drinking water: alterations in neuronal and cerebrovascular
integrity. Brain Res 784: 284-298, 1998.
Strunecka A, Pataocka J. Aluminofluoride complexes: new phosphate
analogues for laboratory investigations and potential danger for
living organisms. www.fluoridation.com/brain3.htm.
Candura SM, Castildi AF, et al. Interaction of aluminum ions with
phosphoinositide metabolism in rat cerebral cortical membranes.
Life Sci 49: 1245-1252, 1991.
Publicover SJ. Brief exposure to the G-protein activator NaF/
AlCl3 induces prolonged enhancement of synaptic transmission in
area of rat hippocampal slices. Expl Brain Res 84: 680-684, 1991.
Brenner A. Macrophagic myofascitiitis: a summery of Dr. Gherardi's
presentations. Vaccine 20LSupp 3): S5-6, 2002.
Lacson AG, D'Cruz CA, et al. Aluminum phagocytosis in quadriceps
muscle following vaccination in children: relationship to
macrophagic myofasciitis. Pediatr Dev Pathol 5: 151-158, 2002.
Flarend RE, Hem SL, et al. In vivo absorption of
aluminum-containing vaccine adjuvants using 26 Al. Vaccine 15:
131401318, 1997.
Authier FJ Cherin P, et al. Central nervous system disease in
patients with macrophagic myofasciitis. Brain 124: 974-983, 2001.
Gherardi RK. Lessons from macrophagic myofasciitis: towards
definition of a vaccine adjuvant-related syndrome. Rev Neurol
(Paris) 159: 162-164, 2003.
Bergfors E, Trollfors B, Inerot A. Unexpectantly high incidence of
persistent itching and delayed hypersensitivity to aluminum in
children after the used of absorbed vaccines from a single
manufacturer. Vaccine 22: 64-69, 2003.
Deloncle R, Fauconneau B, et al. Aluminum L-glutamate complexes in
rat brain cortex: in vivo prevention of aluminum deposit by
magnesium D-aspartate. Brain Res 946: 247-252, 2002.
Mundy WR, Freudenrich TM, Kodavanti PR. Aluminum potentates
glutamate-induced calcium accumulation and iron-induced oxygen
free radical formation in primary neuronal cultures. Mol Chem
Neuropathol 32: 41-57, 1997.
References Concerning Lead
Naatala JT, Loikkanen JJ, et al. Lead amplifies glutamate-induced
oxidative stress. Free Radical Biology Medicine 19: 689-693, 1995.
Morgan RE, Garavan H, et al. Early lead exposure produces lasting
changes in sustained attention, response initiation, and
reactivity to errors. Neurotoxicology and Teratology 23: 519-531,
2001.
Needleman HL, McFarland C, et al. Bone lead levels in adjudicated
delinquents: A case control study. Neurotoxicology and Teratology
24: 711-717, 2002.
Dietrich KN, Ris MD, et al. Early exposure to lead and juvenile
delinquency. Neurotoxicology and Teratology 23: 511-518, 2001.
My References
Blaylock R. Interaction of cytokines, excitotoxins, and reactive
nitrogen and oxygen species in autism spectrum disorders. J. Amer
Nutr Assoc 6: 21-35, 2003.
Blaylock RL. The central role of excitotoxicity in autism spectrum
disorders. J Amer Nutra Assoc 6: 7-19, 2003.
Blaylock RL. Chronic microglial activation and excitotoxicity
secondary to excessive immune stimulation: possible factors in
Gulf War Syndrome and autism. J Amer Phys Surg 9: 46-51, 2004.
©Copyright 2004 Dr. Joseph Mercola. All Rights Reserved. This
content may be copied in full, with copyright, contact, creation and
information intact, without specific permission, when used only in a
not-for-profit format. If any other use is desired, permission in
writing from Dr. Mercola is required.
Disclaimer: The entire contents of this website are based upon the
opinions of Dr. Mercola, unless otherwise noted. Individual articles
are based upon the opinions of the respective author, who retains
copyright as marked. The information on this website is not intended
to replace a one-on-one relationship with a qualified health care
professional and is not intended as medical advice. It is intended
as a sharing of knowledge and information from the research and
experience of Dr. Mercola and his community. Dr. Mercola encourages
you to make your own health care decisions based upon your research
and in partnership with a qualified health care professional.
The Best Defense | THE DMPS ADVOCATES | Glutathione helps Immune system | Thimerosal and Formaldehyde | Flu Vaccine Not Working | Flu Shots | The Truth Behind the Vaccine Coverup
|
|
|
HOME
